Compugen (CGEN) Other Non-Current Assets (2009 - 2026)
Compugen recorded quarterly Other Non-Current Assets of $1.3 million in Q1 2026, little changed quarter-over-quarter from $1.3 million in Q4 2025.
Compugen's Other Non-Current Assets history runs 12 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- In Q1 2026, Other Non-Current Assets changed N/A year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.3 million (changed N/A YoY), while the FY2025 annual figure was $1.3 million, up 276.97% from the prior year.
- Other Non-Current Assets came in at $1.3 million for Q1 2026 at Compugen, roughly flat from $1.3 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $1.3 million in Q1 2026 to a low of $343000.0 in Q4 2024.
- A 5-year average of $731600.0 and a median of $365000.0 in 2023 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets sank 49.23% in 2022 and jumped 276.97% in 2025, its largest moves.
- Compugen's Other Non-Current Assets stood at $362000.0 in 2022, then gained by 0.83% to $365000.0 in 2023, then fell by 6.03% to $343000.0 in 2024, then surged by 276.97% to $1.3 million in 2025, then gained by 0.15% to $1.3 million in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $1.3 million, $1.3 million, and $343000.0 for Q1 2026, Q4 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 12.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 60,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.26 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.13 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 63.55 Mn |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 | 1.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.30 Mn |
| Dec 31, 2025 | 1.29 Mn |
| Sep 30, 2025 | 1.73 Mn |
| Jun 30, 2025 | 1.74 Mn |
| Mar 31, 2025 | 1.64 Mn |
| Dec 31, 2024 | 1.89 Mn |
| Sep 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 922,000.00 |
| Mar 31, 2024 | 934,000.00 |
| Dec 31, 2023 | 1.23 Mn |
| Sep 30, 2023 | 1.91 Mn |
| Jun 30, 2023 | 1.91 Mn |
| Mar 31, 2023 | 1.91 Mn |
| Dec 31, 2022 | 362,000.00 |
| Sep 30, 2022 | 1.91 Mn |
| Jun 30, 2022 | 1.91 Mn |
| Mar 31, 2022 | 1.92 Mn |
| Dec 31, 2021 | 713,000.00 |
| Sep 30, 2021 | 1.91 Mn |
| Jun 30, 2021 | 1.91 Mn |
| Mar 31, 2021 | 1.88 Mn |
| Dec 31, 2020 | 667,000.00 |
| Sep 30, 2020 | 1.87 Mn |
| Jun 30, 2020 | 1.22 Mn |
| Mar 31, 2020 | 1.17 Mn |
| Dec 31, 2019 | 652,000.00 |
| Sep 30, 2019 | 700,000.00 |
| Jun 30, 2019 | 765,000.00 |
| Mar 31, 2019 | 779,000.00 |
| Dec 31, 2018 | 776,000.00 |
| Sep 30, 2018 | 235,000.00 |
| Jun 30, 2018 | 136,000.00 |
| Mar 31, 2018 | 109,000.00 |
| Dec 31, 2017 | 110,000.00 |
| Sep 30, 2017 | 109,000.00 |
| Jun 30, 2017 | 40,000.00 |
| Mar 31, 2017 | 2.60 Mn |
| Dec 31, 2016 | 92,000.00 |
| Sep 30, 2016 | 2.41 Mn |
| Jun 30, 2016 | 96,000.00 |
| Mar 31, 2016 | 2.27 Mn |
| Dec 31, 2015 | 101,000.00 |
| Sep 30, 2015 | 2.13 Mn |
| Jun 30, 2015 | 2.17 Mn |
| Mar 31, 2015 | 2.01 Mn |
| Dec 31, 2014 | 2.02 Mn |
| Sep 30, 2014 | 2.08 Mn |
| Jun 30, 2014 | 2.26 Mn |
| Mar 31, 2014 | 2.16 Mn |
| Dec 31, 2013 | 2.13 Mn |
| Sep 30, 2013 | 185,000.00 |
| Jun 30, 2013 | 201,000.00 |
| Mar 31, 2013 | 251,000.00 |
| Dec 31, 2012 | 1.73 Mn |
| Sep 30, 2012 | 350,000.00 |
| Jun 30, 2012 | 400,000.00 |
| Mar 31, 2012 | 34,000.00 |
| Dec 31, 2011 | 1.47 Mn |
| Sep 30, 2011 | 46,000.00 |
| Jun 30, 2011 | 73,000.00 |
| Mar 31, 2011 | 70,000.00 |
| Dec 31, 2010 | 64,000.00 |
| Sep 30, 2010 | 1.39 Mn |
| Jun 30, 2010 | 1.25 Mn |
| Mar 31, 2010 | 1.30 Mn |
| Dec 31, 2009 | 18,000.00 |
| Sep 30, 2009 | 25,000.00 |
| Jun 30, 2009 | 1.07 Mn |
| Mar 31, 2009 | 1.25 Mn |